ZCH Participated in the Development of ISPAD Global Guidelines for Type 2 Diabetes in Children and Adolescents

In December 2024, The International Society for Pediatric and Adolescent Diabetes (ISPAD) published ISPAD Clinical Practice Consensus Guidelines 2024: Type 2 diabetes in children and adolescents in the authoritative journal Hormone Research in Pediatrics. The endocrinology team of ZCH led by Professor Fu Junfen, President of ZCH, participated in the development of ISPAD global guidelines for Type 2 diabetes in children and adolescents.

The First Clinical Trial of CAR-T therapy for Pediatric Patients with SLE Achieved Great Success at ZCH

ZCH has completed CAR-T therapy for 20 children with refractory systemic lupus erythematosus (SLE) in 2024, and all of these children have successfully stopped using hormones and all biological agents, which is news of a breakthrough in China, even the world. This means that these pediatric patients can get rid of the pain of long-term medication, like a butterfly emerging from the cocoon, and restart a new chapter of normal and healthy life.

ZCH Became the National Characteristic Construction Unit of Maternal Fetal Medicine Integrated Management of Fetal Heart Disease

On December 2, the National Health Commission issued a document, making it clear that 14 teams from 8 provinces (cities) across the country, a total of 24 units, were listed as the first batch of national characteristic construction units of maternal fetal medicine integrated management of fetal heart disease, including the children's Hospital of Zhejiang University School of Medicine (ZCH) together with Zhejiang University Women’s Hospital.

ZCH Completed the World's First CAR-T Treatment for Refractory Juvenile Dermatomyositis

On October 28 2024, the Children's Hospital of Zhejiang University School of Medicine (ZCH) had a breakthrough news: Qingqing (a nickname), the world's first CAR-T treatment for pediatric refractory juvenile dermatomyelitis (JDM) secondary Sjogren's syndrome, has successfully applied at ZCH. The girl is expected to be recovered by suffering for 8 years, now she doesn’t need taking the drug and was discharged from the hospital.

Prof. Fu Junfen Appointed as the APPES President

Children’s National Hospital Delegation Visits ZCH

Summer School on “Adolescent Medicine: Good Health and Well-being” held at ZCH

ZCH Ranks China’s Top Two over the Past Five Years According to the Latest ASTEM Report

The 6th Case of Kidney Transplant Successfully Performed at ZCH

"It's wonderful that my daughter doesn’t need dialysis anymore. Her skin is lightened, her personality is brightened. Thank you so much for giving my child a second chance of life with a kidney transplant", in the urological ward of the Children’s Hospital of Zhejiang University School of Medicine (ZCH), Miao Miao's mother expressed her gratitude while sorting items for the discharge from hospital.

The first SMA child diagnosed through newborn genetic screening in China and treated before onset

In February, Bei Bei's parents took Bei Bei to the Genetics and Metabolism Department of the Children's Hospital of Zhejiang University School of Medicine (ZCH) for a follow-up visit and expressed their heartfelt thanks to the medical team that diagnosed and treated their daughter.